Skip to content
10-Q

Quarterly Report

TENAYA THERAPEUTICS, INC. TNYA

0001193125-25-273239

← back to feed
Filed
Nov 10, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 4, 2025 166.51M sh
Shares Diluted Q3 2025 · Sep 30, 2025 163.35M sh
Shares Diluted Q3 2025 · Sep 30, 2025 145.53M sh
Shares Diluted Q3 2025 · Sep 30, 2024 86.16M sh
Shares Diluted Q3 2025 · Sep 30, 2024 84.29M sh
Capex Q3 2025 · Sep 30, 2025 $551K
Capex Q3 2025 · Sep 30, 2024 $821K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$54.32M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$72.11M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $56.31M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $4.32M
Cash And Equivalents Q3 2025 · Sep 30, 2024 $8.23M
Stockholders Equity Q3 2025 · Sep 30, 2025 $82.87M
Stockholders Equity Q3 2025 · Jun 30, 2025 $99.83M
Stockholders Equity Q3 2025 · Mar 31, 2025 $119.4M
Stockholders Equity Q3 2025 · Dec 31, 2024 $92.85M
Stockholders Equity Q3 2025 · Sep 30, 2024 $112.6M
Stockholders Equity Q3 2025 · Jun 30, 2024 $134M
Stockholders Equity Q3 2025 · Mar 31, 2024 $158.18M
Stockholders Equity Q3 2025 · Dec 31, 2023 $139.42M
Current Liabilities Q3 2025 · Sep 30, 2025 $13.21M
Current Liabilities Q3 2025 · Dec 31, 2024 $15.98M
Total Liabilities Q3 2025 · Sep 30, 2025 $22.11M
Total Liabilities Q3 2025 · Dec 31, 2024 $27.09M
Current Assets Q3 2025 · Sep 30, 2025 $61.24M
Current Assets Q3 2025 · Dec 31, 2024 $67.38M
Total Assets Q3 2025 · Sep 30, 2025 $104.98M
Total Assets Q3 2025 · Dec 31, 2024 $119.94M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.12
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.48
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.30
Eps Diluted Q3 2025 · Sep 30, 2024 −$1.04
Eps Basic Q3 2025 · Sep 30, 2025 −$0.12
Eps Basic Q3 2025 · Sep 30, 2025 −$0.48
Eps Basic Q3 2025 · Sep 30, 2024 −$0.30
Eps Basic Q3 2025 · Sep 30, 2024 −$1.04
Sga Expense Q3 2025 · Sep 30, 2025 $5.57M
Sga Expense Q3 2025 · Sep 30, 2025 $18.75M
Sga Expense Q3 2025 · Sep 30, 2024 $6.36M
Sga Expense Q3 2025 · Sep 30, 2024 $23.24M
Rd Expense Q3 2025 · Sep 30, 2025 $15.36M
Rd Expense Q3 2025 · Sep 30, 2025 $53.81M
Rd Expense Q3 2025 · Sep 30, 2024 $20.35M
Rd Expense Q3 2025 · Sep 30, 2024 $68.05M
Net Income Q3 2025 · Sep 30, 2025 −$20.28M
Net Income Q3 2025 · Sep 30, 2025 −$70.42M
Net Income Q3 2025 · Jun 30, 2025 −$23.28M
Net Income Q3 2025 · Mar 31, 2025 −$26.86M
Net Income Q3 2025 · Sep 30, 2024 −$25.63M
Net Income Q3 2025 · Sep 30, 2024 −$87.29M
Net Income Q3 2025 · Jun 30, 2024 −$29.43M
Net Income Q3 2025 · Mar 31, 2024 −$32.23M
Operating Income Q3 2025 · Sep 30, 2025 −$20.94M
Operating Income Q3 2025 · Sep 30, 2025 −$72.56M
Operating Income Q3 2025 · Sep 30, 2024 −$26.71M
Operating Income Q3 2025 · Sep 30, 2024 −$91.3M
Short Term Investments Q3 2025 · Dec 31, 2024 $57.12M